News

Deal Announcements

BioVex Collects $40 Million Series F Venture Capital

Wednesday, April 1, 2009 5:29:00 AM PDT | VentureDeal Staff
Woburn, Massachusetts  --  Biotechnology company BioVex has raised $40 million in its fifth round of institutional venture capital financing.

BioVex is developing a new class of Biologics for the treatment of cancer and prevention of infectious disease.

The financing round was led by Forbion Capital Partners and included investments by Harris & Harris Group, New Science Ventures, Triathlon Medical Ventures, Innoven Partners and Scottish Equity Partners. The company said the funds would be used to commence its Phase III study for its lead cancer product.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1